Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty
Shoulder & Elbow · 14.07.2026
DOI: 10.1177/17585732261468342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Shoulder & Elbow, online erschienen am 14.07.2026. Verfasst von Hailey Ninness und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Physical Medicine and Rehabilitation, Medical University of South Carolina, Charleston, USA. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed medications; however, they have been associated with increased bleeding risk. Total shoulder arthroplasty (TSA) literature remains lacking. The purpose of this study is to examine the effect of SSRI on postoperative hematologic and surgical complications following primary TSA.
Methods
The PearlDiver Mariner database was queried for patients undergoing primary TSA. SSRI cohort consisted of patients prescribed an SSRI within 365 days preoperatively. Propensity score matching was performed to yield the non-SSRI cohort. Chi-square analysis assessed complication rates, and multivariable logistic regression determined whether SSRI use independently predicted complications. Significance was defined as p < 0.05.
Results
Following chi-square analysis, SSRI cohort demonstrated higher rates of transfusion at 90 days (1.10% vs. 0.90%, p = 0.01) and 1 year (1.66% vs 1.44%, p = 0.04) postoperatively. SSRI cohort had higher rates of revision TSA (3.57% vs. 3.17%, p = 0.003) and mechanical failure (1.70% vs. 1.50%, p = 0.034) at 5 years postoperatively. After multivariable regression, SSRI cohort was not independently predictive of any postoperative complications.
Conclusion
SSRI was not independently predicative of any postoperative hematological or surgical complications following primary TSA. Therefore, SSRI use in TSA appears to be safe to take preoperatively and does not increase complications. Level of evidence Level III – Retrospective cohort study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics and Physical Medicine and Rehabilitation, Medical University of South Carolina, Charleston, USA.
ORCID-Profile: Josef K Eichinger, Richard J Friedman
Zitieren
APA
Ninness, H., Rogalski, B. L., Ponce, B., Eichinger, J. K., & Friedman, R. J. (2026). Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty. Shoulder & Elbow. https://doi.org/10.1177/17585732261468342
Vancouver
Ninness H, Rogalski BL, Ponce B, Eichinger JK, Friedman RJ. Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty. Shoulder & Elbow. 2026. doi:10.1177/17585732261468342
BibTeX
@article{Ninness2026,
author = {Ninness, Hailey and Rogalski, Brandon L and Ponce, Brent and Eichinger, Josef K and Friedman, Richard J},
title = {Selective serotonin reuptake inhibitors and complications following primary total shoulder arthroplasty},
journal = {Shoulder & Elbow},
year = {2026},
doi = {10.1177/17585732261468342}
}
EUVIMED